A selective agonist of the adenosine A2A receptor
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

CGS 21680 (hydrochloride)

Item No. 17126

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
4-[2-[[6-amino-9-(N-ethyl-β-D-ribofuranuronamidosyl)-9H-purin-2-yl]amino]ethyl]-benzenepropanoic acid, monohydrochloride
CAS Number
124431-80-7
Molecular Formula
C23H29N7O6 • HCl
Formula Weight
536.0
Purity
≥98%
Formulation (Request formulation change)
A crystalline solid
Solubility(Learn about Variance in Solubility)
DMF: 20 mg/mlDMSO: 30 mg/mlDMSO:PBS(pH7.2) (1:1): 0.5 mg/ml
λmax
210, 218, 252, 292 nm
SMILES
O[C@H]1[C@@H](O)[C@H](N2C=NC3=C2N=C(NCCC4=CC=C(CCC(O)=O)C=C4)N=C3N)O[C@@H]1C(NCC)=O.Cl
InChi Code
InChI=1S/C23H29N7O6.ClH/c1-2-25-21(35)18-16(33)17(34)22(36-18)30-11-27-15-19(24)28-23(29-20(15)30)26-10-9-13-5-3-12(4-6-13)7-8-14(31)32;/h3-6,11,16-18,22,33-34H,2,7-10H2,1H3,(H,25,35)(H,31,32)(H3,24,26,28,29);1H/t16-,17+,18-,22+;/m0./s1
InChi Key
QPHVMNOEKKJYJO-MJWSIIAUSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $49

    Add

    5 mg

    $130

    Add

    10 mg

    $213

    Add

    25 mg

    $412

    Add
    Product Description

    CGS 21680 is a potent, selective agonist of the adenosine A2A receptor (Ki = 11-46 nM).1,2 It is less effective at adenosine A1 and A3 receptors (Kis = 0.5-3.1 and 0.6-1 µM, respectively) and is without effect at adenosine A2B (Ki > 10 µM).2,3,4,5 CGS 21680 is commonly used to study the actions of the adenosine A2A receptor in cells and tissues.6,7,8

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Ji, X.d., Gallo-Rodriguez, C., and Jacobson, K.A. A selective agonist affinity label for A3 adenosine receptors. Biochem. Biophys. Res. Commun. 203(1), 570-576 (1994).

    2. Kim, H.O., Ji, X.d., Siddiqi, S.M., et al. 2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors. J. Med. Chem. 37(21), 3614-3621 (1994).

    3. Klotz, K.-N., Hessling, J., Hegler, J., et al. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 357(1), 1-9 (1998).

    4. Linden, J., Thai, T., Figler, H., et al. Characterization of human A2B adenosine receptors: Radioligand binding, western blotting, and coupling to Gq in human embryonic kidney 293 cells and HMC-1 mast cells. Mol. Pharmacol. 56(4), 705-713 (1999).

    5. Varani, K., Merighi, S., Gessi, S., et al. [3H]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. Mol. Pharmacol. 57(5), 968-975 (2000).

    6. Cheng, M.K., Doumad, A.B., Jiang, H., et al. Epoxyeicosatrienoic acids mediate adenosine-induced vasodilation in rat prelomerular microvessels (PGMV) via A2A receptors. Br. J. Pharmacol. 141(3), 441-448 (2004).

    7. Ledent, C., Vaugeois, J.M., Schiffmann, S.N., et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2A receptor. Nature 388(6643), 674-678 (1997).

    8. Gnad, T., Scheibler, S., von Kügelgen, I., et al. Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors. Nature 516(7531), 395-399 (2014).